Leo H. Evart Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Sell
887
-58
-6% -$13.5K 0.18% 50
2026
Q1
$231K Buy
+945
New +$220K 0.2% 46
2023
Q3
$203K Sell
1,300
-206
-14% -$34K 0.31% 34
2023
Q2
$249K Hold
1,506
0.35% 30
2023
Q1
$233K Hold
1,506
0.34% 31
2022
Q4
$266K Buy
1,506
+2
+0.1% +$345 0.4% 29
2022
Q3
$246K Sell
1,504
-1
-0.1% -$169 0.37% 31
2022
Q2
$267K Buy
1,505
+3
+0.2% +$535 0.32% 35
2022
Q1
$266K Buy
1,502
+2
+0.1% +$340 0.28% 36
2021
Q4
$257K Buy
+1,500
New +$246K 0.25% 37

Other funds holding JNJ

Leo H. Evart Inc's JNJ Position: Q2 2026 in Review

Leo H. Evart Inc reduced its Johnson & Johnson (JNJ) stake by 6.1% in Q2 2026, selling an estimated $13.5K and leaving 887 shares worth $225K. The position accounts for 0.18% of the portfolio, ranked #50.

Leo H. Evart Inc first reported a position in JNJ in Q4 2021 and has held it in 10 quarters since. The position peaked at $267K in Q2 2022. 4,688 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Leo H. Evart Inc held 887 shares of Johnson & Johnson worth $225K as of Q2 2026.
  • Leo H. Evart Inc sold 58 Johnson & Johnson shares in Q2 2026, an estimated $13.5K.
  • Johnson & Johnson made up 0.18% of Leo H. Evart Inc's portfolio in Q2 2026, its #50 holding.
  • Leo H. Evart Inc first reported a position in Johnson & Johnson in Q4 2021 and has held it in 10 quarters since.
  • Leo H. Evart Inc's Johnson & Johnson position peaked at $267K in Q2 2022.
  • 4,688 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Leo H. Evart Inc's 13F filing for Q2 2026, filed 18 Aug 2026.